Please enable JavaScript to continue using this application.

Compare $ACHV vs $IMMX | Chartloom

Compare

$ACHV vs $IMMX

Achieve Life Sciences Inc · Immix Biopharma Inc

ACHV

Achieve Life Sciences Inc

IMMX

Immix Biopharma Inc

Compare $ACHV vs $IMMX

Comparing Achieve Life Sciences Inc and Immix Biopharma Inc

ACHVAchieve Life Sciences Inc

IMMXImmix Biopharma Inc

ACHVAchieve Life Sciences Inc

Market cap

$761M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

-89.3%

YTD performance

49.1%

52W performance

114.8%

FCF yield

-6.2%

IMMXImmix Biopharma Inc

Market cap

$660M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

—

YTD performance

74.2%

52W performance

272.4%

FCF yield

-5.9%

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

ACHV

IMMX

Detailed metrics comparison

ACHV

Achieve Life Sciences Inc

IMMX

Immix Biopharma Inc

Market Cap

ACHV$761M

IMMX$660M

Enterprise Value

ACHV$728M

IMMX$435M

Price

ACHV$7.41

IMMX$9.46

P/E Ratio

ACHVN/A

IMMXN/A

P/S Ratio

ACHV41.81x

IMMX0.00x

EV/Sales

ACHV39.95x

IMMX0.00x

EV/EBITDA

ACHV0.00x

IMMX0.00x

P/B Ratio

ACHV69.77x

IMMX3.03x

P/FCF Ratio

ACHVN/A

IMMXN/A

EV/FCF

ACHV-15.41x

IMMX-11.12x

PEG Ratio

ACHVN/A

IMMXN/A

Forward P/E (NTM)

ACHVN/A

IMMXN/A

Forward P/S (NTM)

ACHVN/A

IMMXN/A

Revenue (TTM)

ACHV$0

IMMX$0

Revenue Growth (YoY)

ACHV-89.3%

IMMXN/A

Forward Rev Growth

ACHV281.2%

IMMX452.1%

Gross Margin (TTM)

ACHV0.0%

IMMX0.0%

Operating Margin (TTM)

ACHV0.0%

IMMX0.0%

EBITDA Margin (TTM)

ACHV0.0%

IMMX0.0%

Net Margin (TTM)

ACHV0.0%

IMMX0.0%

FCF Margin (TTM)

ACHVN/A

IMMXN/A

Net Income (TTM)

ACHV$-114M

IMMX$-40M

FCF (TTM)

ACHV$-47M

IMMX$-39M

EPS (TTM)

ACHV-$1.22

IMMX-$0.63

ROE (TTM)

ACHV-19349.0%

IMMX-3844.0%

ROA (TTM)

ACHV-14373.0%

IMMX-3472.0%

ROIC (TTM)

ACHV-13245.0%

IMMX-3844.0%

Cash

ACHV$48M

IMMX$225M

Debt

ACHV$15M

IMMX$0

Net Cash/Debt

ACHV$33M

IMMX$225M

Current Ratio (TTM)

ACHV0.95x

IMMX25.13x

Quick Ratio (TTM)

ACHV0.95x

IMMX24.98x

Debt/Equity (TTM)

ACHV1.40x

IMMX0.00x

Debt/Assets (TTM)

ACHV0.0%

IMMX0.0%

Interest Coverage (TTM)

ACHVN/A

IMMXN/A

Net Debt/EBITDA (TTM)

ACHV0.00x

IMMX0.00x

Beta

ACHV2.44

IMMX0.22

52W Performance

ACHV114.8%

IMMX272.4%

YTD Performance

ACHV49.1%

IMMX74.2%

% from 52W High

ACHV-14.2%

IMMX-37.4%

% from 52W Low

ACHV182.8%

IMMX309.5%

Asset Turnover (TTM)

ACHV0.33x

IMMX0.00x

FCF Yield (TTM)

ACHV-6.2%

IMMX-5.9%

Earnings Yield (TTM)

ACHV-15.0%

IMMX-6.0%

Dividend Yield (TTM)

ACHVN/A

IMMXN/A

Rule of 40

ACHV-89.3

IMMX0.0

EV/GP/RG

ACHVN/A

IMMXN/A

Ticker research

View ACHV research View IMMX research

Metric	ACHV Achieve Life Sciences Inc	IMMX Immix Biopharma Inc
Market & Valuation
Market Cap	$761M	$660M
Enterprise Value	$728M	$435M
Price	$7.41	$9.46
P/E Ratio	N/A	N/A
P/S Ratio	41.81x	0.00x
EV/Sales	39.95x	0.00x
EV/EBITDA	0.00x	0.00x
P/B Ratio	69.77x	3.03x
P/FCF Ratio	N/A	N/A
EV/FCF	-15.41x	-11.12x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	N/A
Revenue & Growth
Revenue (TTM)	$0	$0
Revenue Growth (YoY)	-89.3%	N/A
Forward Rev Growth	281.2%	452.1%
Profitability
Gross Margin (TTM)	0.0%	0.0%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	0.0%	0.0%
Net Margin (TTM)	0.0%	0.0%
FCF Margin (TTM)	N/A	N/A
Net Income (TTM)	$-114M	$-40M
FCF (TTM)	$-47M	$-39M
EPS (TTM)	-$1.22	-$0.63
ROE (TTM)	-19349.0%	-3844.0%
ROA (TTM)	-14373.0%	-3472.0%
ROIC (TTM)	-13245.0%	-3844.0%
Financial Health
Cash	$48M	$225M
Debt	$15M	$0
Net Cash/Debt	$33M	$225M
Current Ratio (TTM)	0.95x	25.13x
Quick Ratio (TTM)	0.95x	24.98x
Debt/Equity (TTM)	1.40x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	2.44	0.22
52W Performance	114.8%	272.4%
YTD Performance	49.1%	74.2%
% from 52W High	-14.2%	-37.4%
% from 52W Low	182.8%	309.5%
Efficiency & Yields
Asset Turnover (TTM)	0.33x	0.00x
FCF Yield (TTM)	-6.2%	-5.9%
Earnings Yield (TTM)	-15.0%	-6.0%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	-89.3	0.0
EV/GP/RG	N/A	N/A
Ticker research	View ACHV research	View IMMX research

Valuation

P/S Ratio

IMMX

0.00x

ACHV

41.81x

EV/FCF

ACHV

-15.41x

IMMX

-11.12x

Growth & revenue

Revenue Growth TTM

ACHV

-89.3%

Forward Revenue Growth

IMMX

452.1%

ACHV

281.2%

Profitability & performance

Gross Margin

ACHV

0.0%

IMMX

0.0%

ROE

IMMX

-3844.0%

ACHV

-19349.0%

FCF Yield %

IMMX

-5.9%

ACHV

-6.2%

52-Week Performance

IMMX

272.4%

ACHV

114.8%

Detailed metrics comparison

ACHV

Achieve Life Sciences Inc

IMMX

Immix Biopharma Inc

Market Cap

ACHV$761M

IMMX$660M

Enterprise Value

ACHV$728M

IMMX$435M

Price

ACHV$7.41

IMMX$9.46

P/E Ratio

ACHVN/A

IMMXN/A

P/S Ratio

ACHV41.81x

IMMX0.00x

EV/Sales

ACHV39.95x

IMMX0.00x

EV/EBITDA

ACHV0.00x

IMMX0.00x

P/B Ratio

ACHV69.77x

IMMX3.03x

P/FCF Ratio

ACHVN/A

IMMXN/A

EV/FCF

ACHV-15.41x

IMMX-11.12x

PEG Ratio

ACHVN/A

IMMXN/A

Forward P/E (NTM)

ACHVN/A

IMMXN/A

Forward P/S (NTM)

ACHVN/A

IMMXN/A

Revenue (TTM)

ACHV$0

IMMX$0

Revenue Growth (YoY)

ACHV-89.3%

IMMXN/A

Forward Rev Growth

ACHV281.2%

IMMX452.1%

Gross Margin (TTM)

ACHV0.0%

IMMX0.0%

Operating Margin (TTM)

ACHV0.0%

IMMX0.0%

EBITDA Margin (TTM)

ACHV0.0%

IMMX0.0%

Net Margin (TTM)

ACHV0.0%

IMMX0.0%

FCF Margin (TTM)

ACHVN/A

IMMXN/A

Net Income (TTM)

ACHV$-114M

IMMX$-40M

FCF (TTM)

ACHV$-47M

IMMX$-39M

EPS (TTM)

ACHV-$1.22

IMMX-$0.63

ROE (TTM)

ACHV-19349.0%

IMMX-3844.0%

ROA (TTM)

ACHV-14373.0%

IMMX-3472.0%

ROIC (TTM)

ACHV-13245.0%

IMMX-3844.0%

Cash

ACHV$48M

IMMX$225M

Debt

ACHV$15M

IMMX$0

Net Cash/Debt

ACHV$33M

IMMX$225M

Current Ratio (TTM)

ACHV0.95x

IMMX25.13x

Quick Ratio (TTM)

ACHV0.95x

IMMX24.98x

Debt/Equity (TTM)

ACHV1.40x

IMMX0.00x

Debt/Assets (TTM)

ACHV0.0%

IMMX0.0%

Interest Coverage (TTM)

ACHVN/A

IMMXN/A

Net Debt/EBITDA (TTM)

ACHV0.00x

IMMX0.00x

Beta

ACHV2.44

IMMX0.22

52W Performance

ACHV114.8%

IMMX272.4%

YTD Performance

ACHV49.1%

IMMX74.2%

% from 52W High

ACHV-14.2%

IMMX-37.4%

% from 52W Low

ACHV182.8%

IMMX309.5%

Asset Turnover (TTM)

ACHV0.33x

IMMX0.00x

FCF Yield (TTM)

ACHV-6.2%

IMMX-5.9%

Earnings Yield (TTM)

ACHV-15.0%

IMMX-6.0%

Dividend Yield (TTM)

ACHVN/A

IMMXN/A

Rule of 40

ACHV-89.3

IMMX0.0

EV/GP/RG

ACHVN/A

IMMXN/A

Ticker research

View ACHV research View IMMX research

Metric	ACHV Achieve Life Sciences Inc	IMMX Immix Biopharma Inc
Market & Valuation
Market Cap	$761M	$660M
Enterprise Value	$728M	$435M
Price	$7.41	$9.46
P/E Ratio	N/A	N/A
P/S Ratio	41.81x	0.00x
EV/Sales	39.95x	0.00x
EV/EBITDA	0.00x	0.00x
P/B Ratio	69.77x	3.03x
P/FCF Ratio	N/A	N/A
EV/FCF	-15.41x	-11.12x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	N/A
Revenue & Growth
Revenue (TTM)	$0	$0
Revenue Growth (YoY)	-89.3%	N/A
Forward Rev Growth	281.2%	452.1%
Profitability
Gross Margin (TTM)	0.0%	0.0%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	0.0%	0.0%
Net Margin (TTM)	0.0%	0.0%
FCF Margin (TTM)	N/A	N/A
Net Income (TTM)	$-114M	$-40M
FCF (TTM)	$-47M	$-39M
EPS (TTM)	-$1.22	-$0.63
ROE (TTM)	-19349.0%	-3844.0%
ROA (TTM)	-14373.0%	-3472.0%
ROIC (TTM)	-13245.0%	-3844.0%
Financial Health
Cash	$48M	$225M
Debt	$15M	$0
Net Cash/Debt	$33M	$225M
Current Ratio (TTM)	0.95x	25.13x
Quick Ratio (TTM)	0.95x	24.98x
Debt/Equity (TTM)	1.40x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	2.44	0.22
52W Performance	114.8%	272.4%
YTD Performance	49.1%	74.2%
% from 52W High	-14.2%	-37.4%
% from 52W Low	182.8%	309.5%
Efficiency & Yields
Asset Turnover (TTM)	0.33x	0.00x
FCF Yield (TTM)	-6.2%	-5.9%
Earnings Yield (TTM)	-15.0%	-6.0%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	-89.3	0.0
EV/GP/RG	N/A	N/A
Ticker research	View ACHV research	View IMMX research